uniQure (QURE) Stock Price & Analysis
QURE$25.70+0.73 +2.92%
$1.78B
Market Cap
-6.18
P/E
24.58
Forward P/E
63
Score
uniQure (QURE) Stock Price & Analysis
QURE price $25.70 +0.73 +2.92%
- Ticker
- QURE
- Price
- $25.70
- Change
- +0.73 +2.92%
- Market cap ?
- $1.78B
- P/E ?
- -6.18
- Forward P/E ?
- 24.58
- Dividend yield ?
- 0.00%
- Beta ?
- 0.94
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 63
- Value
- 58
- Quality
- 33
- Growth
- 98
Stocklytics score rationale: value 58, quality 33, growth 98.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 25098000 | 13107000 | 11284000 | 7281000 | 37514000 | 524002000 | 106483000 | 15843000 | 27119000 | 16098000 |
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in phase I/II clinical study for the treatment of Huntington’s disease. The company also…
Insights · Dividends · Forecast · Financials · Learn